Angiotensin-converting enzyme inhibitors as possible exacerbating drugs in psoriasis.
Gilleaudeau
P
P
Laboratory for Investigative Dermatology, Rockefeller University, New York, NY 10021.
Vallat
V P
VP
Carter
D M
DM
Gottlieb
A B
AB
D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000473:pathology*; D012867:Skin / Q000473:pathology
D000806:Angiotensin-Converting Enzyme Inhibitors